Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc L Turner

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Regenerative Medicine|September 13, 2018
Quality control guidelines for clinical-grade human induced pluripotent stem cell linesStephen Sullivan, Glyn N Stacey, Chihiro Akazawa, et al.
Cytotherapy|May 17, 2020
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.
Circulation. Cardiovascular Imaging|July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansJennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
Plos Pathogens|October 28, 2020
Rapid deployment of SARS-CoV-2 testing: The CLIAHUBEmily D Crawford, Irene Acosta, Vida Ahyong, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Medicine|January 10, 2025
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trialPaul N Brennan, Mark MacMillan, Thomas Manship, et al.
Regenerative Medicine|September 13, 2018
Quality control guidelines for clinical-grade human induced pluripotent stem cell linesStephen Sullivan, Glyn N Stacey, Chihiro Akazawa, et al.
Cytotherapy|May 17, 2020
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.
Circulation. Cardiovascular Imaging|July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansJennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
Plos Pathogens|October 28, 2020
Rapid deployment of SARS-CoV-2 testing: The CLIAHUBEmily D Crawford, Irene Acosta, Vida Ahyong, et al.
Pageof 6